Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Panagiotis Ntziachristos
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
19
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2024 → 31 December 2027
Characterization and targeting of the function of the HNRNPC RNA binding protein in T-cell leukemia
Funding: Research Foundation - Flanders (FWO)
01 January 2023 → 31 December 2026
Deregulated mRNA transcription and protein translation in the transformation of normal T-cells to malignant cells.
Funding: Regional and community funding: Special Research Fund
As
Administrative supervisor
29 June 2023 → 21 September 2025
Characterize the role of kinases in controlling transcript homeostasis in acute leukemia
Doctoral researcher: Luyao Xu
08 June 2022 → 21 September 2025
Characterizing and targeting aberrant splicing activity in acute leukemia
Doctoral researcher: Cristina Borin
19 November 2024 → 21 September 2025
Characterizing and targeting the mechanisms of T-cell acute lymphoblastic leukemia blast metastasis in the central nervous system
Doctoral researcher: Freya De Muyer
As
PhD Supervisor
22 February 2024 → 21 September 2025
Drug response profiling of T-cell acute lymphoblastic leukemia to optimize salvage therapeutic strategies for refractory/relapsed patients
Doctoral researcher: Hannah Van Steenberge
16 March 2022 → 22 September 2024
PROTACs to degrade oncogenic transcription factors in acute leukemia
Doctoral researcher: Chaimae El Hadri
As
Promotor
01 September 2021 → 31 August 2026
BOF-ZAP professorship in cancer epigenetics
Fellow: Panagiotis Ntziachristos
Funding: Regional and community funding: Special Research Fund
01 September 2021 → 31 August 2026
Characterizing and targeting aberrant splicing activity in acute leukemia
Funding: Research Foundation - Flanders (FWO)
01 November 2022 → 31 October 2025
Cofunding core facility - Flow cytometry
Funding: Regional and community funding: Special Research Fund
01 February 2024 → 31 January 2027
Cofunding Core Facility - Patient-derived xenograft models
Funding: Regional and community funding: Special Research Fund
01 March 2022 → 28 February 2026
Oncogenese en resistentie tegen therapie bij bloedkankers begrijpen en gerichten
Funding: Regional and community funding: Special Research Fund
01 January 2021 → 31 December 2023
On the road to excellence in unravelling the (epi)genetic landscape of hematologic neoplasms
Funding: European funding: framework programme
01 November 2023 → 31 October 2027
The role of aberrant splicing in apoptosis and therapy resistance in T-cell leukemia
Fellow: Cristina Borin
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
01 May 2022 → 30 April 2026
A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies
Funding: Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
Democratizing High-Throughput Next Generation Sequencing across different Life Science Fields: the AVITI Next Generation Sequencer.
Funding: Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
ThirdGenT: linking third-generation sequencing of (epi)genomes, (epi)transcriptomes and translatomes to life sciences revolutionizes oncology, rare diseases, microbiology, cell and gene technology, developmental and computational biology
Funding: Research Foundation - Flanders (FWO)
As
Fellow
01 September 2021 → 31 August 2026
BOF-ZAP professorship in cancer epigenetics
Fellow: Panagiotis Ntziachristos
Funding: Regional and community funding: Special Research Fund
As
Researcher
01 October 2023 → 30 September 2027
Drug response profiling of T-cell acute lymphoblastic leukemia to optimize salvage therapeutic strategies for refractory/relapsed patients
Fellow: Hannah Van Steenberge
Funding: Regional and community funding: Special Research Fund